Published: 29.09.2022 Related countries:  U.S.A. U.S.A.

BTL EMFACE is a first-of-its-kind aesthetic medicine technology that simultaneously treats facial muscles, skin and connective tissue.

BTL, the authority in non-invasive body sculpting therapies, is thrilled to unveil its latest innovative breakthrough: EMFACE - The first and only hands-free device that simultaneously treats facial skin and muscles in just 20 minutes.

Emface simultaneously emits both synchronized radio frequency and HIFES-brand energies. The homogenous radio frequency heats collagen and elastin fibers while the HIFES(TM) stimulation emits thousands of pulses per session to contract delicate facial muscles. The recommended treatment course for the EMFACE therapy calls for four 20-minute sessions, with each session completed 2-14 days apart.

BTL's clinical research of Emface showed the treatment results in less wrinkles and more lift. The findings from 9 clinical studies concluded that participants who completed the recommended treatment course experienced, on average, a 37% reduction in wrinkles, 30% increase in facial muscle tone, and 23% lifting effect - with optimal results seen 6-12 weeks after final treatment.

Founded in 1993, BTL has grown to become one of the world's major medical and aesthetic equipment manufacturers. With 2,800 employees located in more than 71 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL's brands include EMFACE, EMSCULPT NEO, EMSCULPT, EMSELLA, EMTONE, EMFEMME, and BTL Exilis ULTRA.


Preseented by the team of employees of CzechTrade Chicago, USA.